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Introduction
The European Region has passed the half-way 
point of the Health 2020 implementation period. 
In this chapter we assess the extent to which 
progress has been made towards the targets as 
defined in the Health 2020 monitoring framework. 
It provides an overview of progress made by the 
Member States towards reaching the Health 2020 
targets (1) at the regional level in relation to the 
agreed 2010 baseline. The Health 2020 mon-
itoring framework (Annex 1) is the backbone of 
this report. It has three main components: bur-
den of disease and risk factors; healthy people, 
well-being and determinants; and processes, 
governance and health systems (1). Each area is 
linked to one or more targets (six in total). There 
are 19 core indicators and 18 additional indi-
cators by which to measure progress on the six 
targets. The narratives, information and data illus-
trations in this chapter are organized numerically 
according to the Health 2020 main targets and 
indicators. This introduction provides a very brief 
summary of progress made on the Health 2020 
targets but a more detailed overview is provided 
by target in the following sections of this chapter.
Among the many monitoring frameworks in oper-
ation in the European Region, there are three main 
frameworks which overlap to a  significant degree: 
the 17 sustainable development goals (SDGs) which 
are part of the comprehensive Agenda 2030 (2) 
framing global sustainable development; the Global 
action plan for the prevention and control of non-
communicable diseases 2013–2020 (3); and the 
European regional health policy framework Health 
2020 (4, 5).
Measuring the impact of these commitments 
constitutes a vital part of the evidence-informed 
health policy-making cycle in the Region. It re-
flects the importance of setting goals and using 
monitoring frameworks to focus the generation 
of evidence, and enables measurement of change 
in health and well-being and impact of policy 
over time. In order to address concerns raised by 
Member States on the high burden of reporting re-
quirements to WHO and other international bod-
ies, the Member States at the 67th session of the 
Regional Committee for Europe (RC67) agreed to 
adopt a joint monitoring framework (JMF) for re-
porting on indicators for the SDGs, Health 2020 
and the Global action plan for the prevention and 
control of noncommunicable diseases, through 
the endorsement of Resolution EUR/RC67/R3 (6) 
in September 2017. The Division of Information, 
Evidence, Research and Innovation at the WHO 
Regional Office for Europe therefore established 
an expert group to propose a common set of indi-
cators for the JMF. A total of 40 indicators were 
recommended by the group to go forward for 
a detailed web-based consultation with Member 
States in the spring of 2018. At the time of writ-
ing, this proposal is still in consultation with the 
Member States and will be proposed for adoption 
at the 68th Regional Committee for Europe in Sep-
tember 2018.
If adopted, the JMF – with a common set of indica-
tors for the SDGs, Health 2020 and the Global mon-
itoring framework on noncommunicable diseases 
(NCDs) – will help to reduce the burden of report-
ing and streamline data collection in the Region. In 
addition, the JMF will help Member States prioritize 
data collection efforts and align their national SDG 
monitoring targets with international monitoring. 
If adopted, the JMF will also enhance the cover-
age of international reporting across public health 
domains.
The Health 2020 framework is the central 
health policy for the Region, and emphasizes 
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a whole-of-government, whole-of-society and life-
course approach to policy-making. It also calls 
for the measurement of these new concepts, in-
cluding community resilience, empowerment and 
a life-course approach. A rapid and broad uptake 
of Health 2020 in Member States had already 
been observed and reported in the previous Euro-
pean Health Reports for 2012 and 2015, just a few 
years after its inception at the 62nd session of the 
Regional Committee in 2012 (4).
Over the past few years, the Region has main-
tained this progress yet is still facing a  number 
of challenges. Premature mortality from the four 
major NCDs, as well as all-cause (all ages) mor-
tality, including mortality from all external causes, 
continues to decline in the Region. At the same 
time, child vaccination rates remain at a  high 
level. However, lifestyle-related indicators such 
as tobacco smoking rates, alcohol consumption 
levels, and the high prevalence of overweight and 
obesity are still presenting major challenges for 
a number of countries in the Region. There was 
considerable variation in country rates with large 
differences in the prevalence of overweight and 
obesity among adolescents, and across gender. 
Similarly, there are wide variations between the 
sexes and between the Member States in prema-
ture mortality from the four major NCDs, all-cause 
(all ages) mortality rates, mortality rates from all 
external causes and tobacco smoking rates.
Average life expectancy at birth in the European 
Region increased from 76.7 years in 2010 to 
77.9 years in 2015 which is an average annual in-
crease of 0.24 years. The gaps in life expectancy 
between the sexes and between countries are 
decreasing. However, the difference in life expec-
tancy between the countries with the highest and 
lowest life expectancy at birth is still more than 10 
years. Therefore, continued monitoring is required 
to ensure that the consistent improvement of cur-
rent trends is maintained.
The number of countries that have implemented 
a policy or strategy to address inequality or social 
determinants increased from 29 in 2010 to 42 
of the 53 countries in the Region in 2016. At the 
same time, the Region has experienced a signifi-
cant reduction in infant mortality rates. In 2015, 
the regional average infant mortality was 6.8 in-
fant deaths per 1000 live births. The Region has 
made some improvements in the proportion of 
children of official primary school age that are not 
enrolled in school, which decreased from 2.6% in 
2010 to 2.3% in 2015, yet there is wide variation 
between countries.
Differences between countries in unemployment 
rates decreased, but there is still a  wide varia-
tion. The regional unemployment rate slightly de-
creased from 8.9% in 2010 to 8.7% in 2015. Simi-
larly, the regional average income inequality (Gini 
coefficient) has slightly decreased over the last 
decade from 34.3 in 2004 to 33.7 in 2015.
Considering well-being indicators, the Region 
has an overall life satisfaction score (subjective 
well-being indicator) of 6. Some countries have 
relatively low overall average self-reported life 
satisfaction scores of 5 or below and other coun-
tries, with the highest scores in the world, reach 
7.6. Concerning objective well-being indicators, 
there is a  high level of social connectedness in 
the Region: 81% of the population aged 50 years 
and above reported that they had social support 
through family or friends in 2015. However, there 
is a large variation in reported values that reflects 
a  gradient of social connectedness across the 
Member States. In contrast, the percentage of 
people aged 65 years and above who live alone 
has increased from 29.9% in 2010 to 30.9% in 
2016. In 2015, more than 90% of the European 
population had access to improved sanitation fa-
cilities and piped drinking water. Yet there were 
some inequalities in access between the urban 
and rural areas, ranging from 93.1% to 100% for 
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populations in urban areas and from 66.7% to 
100% for populations in rural areas.
In relation to indicators on universal health cov-
erage and the right to health, the WHO European 
regional average total health expenditure as a per-
centage of gross domestic product (GDP) steadily 
increased from 6.8% in 2000 to 8.5% in 2009 but 
then fell slightly and remained static at 8.3% in 
2010 and 8.2% in 2014. At the same time, there was 
an increase in the proportion of private household 
out-of-pocket expenditure on health between 2010 
(25.5%) and 2014 (26.6%).
The regional average maternal mortality rate de-
creased from 13 deaths per 100 000 live births in 
2010 to 11 deaths per 100 000 live births in 2015. 
Similarly positive, the treatment success rate for 
new cases of pulmonary tuberculosis (TB) in the 
Region slightly increased from 74% in 2010 to 77% 
in 2015. There were, however, large differ ences in 
treatment success rates between the Member 
States, which ranged from 10% to a maximum val-
ue of 100% in 2015.
By 2016, the Region had already made consider-
able progress in relation to Health 2020 Target 6, 
with 88.4% of the countries (38 out of the 43 coun-
tries in the Region that responded) reporting that 
they had set targets for health and well-being.
Health 2020 supports the SDGs for health with 
the social determinants of health and illness ad-
dressed through the targets and indicators. Sim-
ilarly, prevention and control of NCDs and their 
risk factors are at the heart of Health 2020 pol-
icy. Accordingly, by embracing Health 2020 prin-
ciples and targets, the Member States have put 
themselves in a strong position to meet both the 
SDGs of Agenda 2030 and the goals of the Global 
action plan for the prevention and control of NCDs 
2013–2020.
Target 1.  
Reduce premature mortality in Europe by 2020
Introduction
Since the beginning of the millennium, Europe has 
maintained a  consistent reduction in the risk of 
premature death from the four major NCDs (car-
diovascular diseases, cancer, diabetes mellitus 
and chronic respiratory diseases) among people 
aged 30 to 70 years. Similar progress has also 
been made in relation to all-cause mortality rates. 
In fact, a 2017 review of progress has established 
that the WHO European Region is likely to achieve 
SDG Target 3.4 earlier than 2030, and will most 
probably exceed it significantly (7).
The most recent data, reported for 2014, reveal 
that Europe has been making clear progress over 
recent decades in reducing premature mortality 
from NCDs. Yet, there is a need to sustain this pro-
gress in order to reach the target. Similar progress 
was made in all-cause (all ages) mortality rates 
but there are large inequalities in mortality rates in 
Europe between the sexes, and between countries.
Tobacco smoking rates present a  challenge for 
Europe as rates for the adult population are the 
highest of the six WHO regions though the figures 
varied between countries and age groups. Similarly, 
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despite the decreasing trend of alcohol consump-
tion in the Region, levels of consumption among 
the adult population are still the highest in the 
world which poses a  threat to population health. 
Differences in the levels of alcohol consumption 
between countries remain large.
The prevalence of overweight and obesity among 
adults in the European Region is high and on the 
rise. In most countries in the Region, the prevalence 
of overweight was higher among men, while the 
prevalence of obesity was higher among women. 
On the other hand, the reported prevalence of over-
weight and obesity among adolescents varied be-
tween genders, countries and age groups.
Child immunization coverage has increased since 
the year 2000. Nevertheless, vigilance is needed as 
differences between countries persist. In 2015, sev-
eral countries still had vaccination rates below 90%.
There is a steady decline in the average regional 
mortality rates from all external causes and inju-
ries. However, there were very wide inequalities in 
the death rates between the sexes and between 
countries.
Box 2.1. Health 2020 Target 1 and indicators
Target 1 “Reduce premature mortality in Europe by 2020” aims to reduce premature mortality 
related to noncommunicable diseases, selected vaccine-preventable communicable 
diseases and external causes.
This Health 2020 target has two quantifications, each measured with one or more core 
indicators:
• A 1.5% relative annual reduction in overall (four causes combined) premature mortality 
from cardiovascular diseases, cancer, diabetes mellitus and chronic respiratory diseases 
by 2020.
• Achieved and sustained elimination of selected vaccine-preventable diseases 
(poliomyelitis (polio), measles and rubella) and prevention of congenital rubella syndrome.
The core indicators are:
1. Age-standardized overall premature mortality rate (from 30 to under 70 years old) for 
four major noncommunicable diseases.
2. Age-standardized prevalence of current (includes both daily and non-daily or occasional) 
tobacco use among people aged 18 years and over.
3. Total (recorded and unrecorded) per capita alcohol consumption among people aged 
15 years and over within a calendar year (litres of pure alcohol).
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Box 2.1 contd.
4. Age-standardized prevalence of overweight and obesity in people aged 18 years and 
over (defined as a body mass index (BMI) ≥25 kg/m² for overweight and ≥30 kg/m² for 
obesity).
5. Percentage of children vaccinated against measles (one dose by second birthday), polio 
(three doses by first birthday) and rubella (one dose by second birthday).
6. Age-standardized mortality rates from all external causes and injuries.
There are a number of additional indicators for this target:
1. Standardized mortality rate from all causes.
2. Prevalence of weekly tobacco use among adolescents.
3. Heavy episodic drinking (60 g of pure alcohol or around six standard alcoholic drinks on 
at least one occasion weekly) among adolescents.
4. Prevalence of overweight and obesity among adolescents (defined as BMI-for-age value 
above +1 Z-score and +2 Z-score relative to the 2007 WHO growth reference median, 
respectively).
5. Age-standardized mortality rates from:
a. motor vehicle traffic accidents
b. accidental poisoning
c. alcohol poisoning
d. suicide
e. accidental falls
f. homicides and assaults.
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Box 2.2. WHO STEPwise approach to Surveillance (STEPS) in Europe
Surveillance of the main noncommunicable diseases (NCDs) and their risk factors is essential 
for policy-making, including planning, monitoring and assessing the impact of specific 
interventions and policies to limit the negative effects of NCDs. An important challenge for 
NCD monitoring is the multiplicity of behavioural and biological risk factors involved and the 
difficulties for their capture by traditional surveillance systems. The WHO STEPS survey is 
an internationally comparable, highly standardized, integrated tool that European countries 
are implementing for the surveillance of NCD risk factors (8). STEPS survey data are helping 
policy-makers and health professionals to determine the national prevalence and patterns of 
risk factors, allowing them to define policies and programmes for the prevention and control 
of NCDs. The repeated utilization of survey data also enables countries to monitor trends 
and evaluate the effectiveness of public health and health care management interventions. 
The STEPS survey implementation allows them to further develop their national capacity for 
NCD monitoring and surveillance, thereby meeting several of the United Nations time-bound 
targets for improving capacities and response to these diseases.
STEPS collected data, in many cases for the first time, on tobacco use, harmful use of 
alcohol, unhealthy diet, insufficient physical activity, overweight and obesity, raised blood 
pressure, raised blood glucose, abnormal blood lipids and average population salt/sodium 
intake. WHO has sponsored and technically supported the implementation of 11 STEPS 
surveys in eastern European and central Asian countries. In addition, other countries have 
plans to complete STEPS survey for the first time, while Azerbaijan, Kyrgyzstan, Republic of 
Moldova, Turkmenistan and Uzbekistan will conduct a second round in 2017–2018. Overall, 
by the end of 2018, these surveys will have included more than 40 000 people aged 18 to 69 
years, who have been interviewed, physically measured and their blood and urine chemically 
examined, thus increasing NCD surveillance to cover nearly 200 million people in Europe 
(approximately 25% of the population of the WHO European Region).
To date, results from these surveys have shown high levels of different behavioural and 
biological clusters of three to five risk factors among individuals, which tend to be more 
common among men than women, and increase rapidly with age. These results call for 
increasing preventive policies and measures to reduce such factors at the population level. In 
addition, other health care-related results also helped to determine whether people with raised 
blood pressure, sugar and cholesterol levels know of their situation, are on treatment and 
effectively managed. In general, less than 30% of those with raised physical and biochemical 
levels are on specific medication. Furthermore, between 10 and 20% of people aged 40 years 
and over have a 30% or higher cardio-metabolic risk score of having an acute myocardial 
infarction or stroke in the next 10 years. However, over half of them are already on treatment 
or receiving counselling to reduce their risk of such events. This means that health care 
systems are already working to reduce the occurrence of disease by tacking the needs of 
high-risk individuals, although there is still room to further improve health care management.
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Summary of progress: Reduction 
of premature mortality from the 
four major NCDs
Europe needs to sustain progress made 
so far to reach the target
In 2014, the age-standardized overall premature 
mortality rate for the four major NCDs (cardio-
vascular diseases, cancer, diabetes mellitus and 
chronic respiratory diseases) in the WHO Euro-
pean Region was 379 per 100 000 (see Fig. 2.1). 
This is lower than the reported baseline regional 
average in 2010 of 421 per 100 000. This repre-
sents an average annual reduction of around 2% 
between 2010 and 2014 which indicates that the 
WHO European Region is on track to achieve the 
policy target of a  1.5% relative annual reduction 
in overall pre mature mortality from the four ma-
jor NCDs by 2020. With available data from only 
40 countries in the Region for 2014, however, this 
should be regarded as a  preliminary estimate, 
which will need to be assessed again once the re-
maining data are received.
Figure 2.1. Age-standardized overall premature mortality rate (from 30 to under 70 years old) for 
four major noncommunicable diseases (cardiovascular diseases, cancer, diabetes mellitus and 
chronic respiratory diseases), deaths per 100 000 population
Source: Health for All database on the WHO European Health Information Gateway (9).
Note: The European regional average is calculated for those years when more than 26 countries (50% of 53 Member States) 
reported in that year. See Annex 2 for detailed notes.
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There is a  wide variation in the age-standardized 
overall premature mortality rates for the four major 
NCDs between the sexes and across the Member 
States. The average regional rate in 2014 was still 
much higher for males (524 per 100 000) than for 
females (255 per 100  000). In the same year, the 
rates ranged from 211 per 100  000 in the Nordic 
countries to 618 per 100  000 in the countries of 
the Commonwealth of Independent States (CIS). 
These differences are even more pronounced at 
the country level where there is a  very wide vari-
ation between the maximum (656 per 100 000) and 
mini mum (183 per 100 000) age-standardized pre-
mature mortality rates reported for 2014.
Caution is needed, however, in interpreting trends 
in the maximum and minimum age-standardized 
premature mortality rates because these repre-
sent the highest and lowest values reported in the 
Region in a given year. They may be, in some cases, 
influenced by gaps or delays in national reporting.
Continued decline in all-cause mortality 
rates in Europe with a wide variation 
between gender and countries
An additional indicator for this target is the overall 
age-standardized mortality rates (1) from all caus-
es (all ages). This continued to decline in the WHO 
European Region, reaching 715 deaths per 100 000 
in 2015 (see Fig. 2.2). It is lower than the report-
ed baseline regional average in 2010 of 786 per 
100 000, and much lower than the mortality rate re-
ported at the beginning of the millennium (in 2000) 
of 949 deaths per 100 000 (see Fig. 2.2).
However, as for the previous indicator, complete 
data are not available as only 27 countries report-
ed data for 2015. Therefore, mortality rates might 
change once more data are received.
As for premature mortality rates, there is a wide 
variation in all-cause, all-age mortality rates be-
tween the sexes and across the Member States.
The gender gap for this mortality indicator has 
steadily reduced since 2000. Yet, the latest availa-
ble data (2015) show that the regional average mor-
tality rate for males (930 per 100 000 population) is 
still higher than for females (551 per 100 000).
Similarly, there is a  very wide variation in 
age-standardized mortality rates from all causes 
(all ages) between the Member States. The re-
ported maximum and minimum mortality rates 
were 1095 per 100 000 and 460 per 100 000 in 
2015 (see Fig. 2.2).
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Tobacco smoking rates present a main 
challenge for the Region
A core indicator for this target is age-standard-
ized prevalence of current tobacco use among 
people aged 18 years and over (1). “Tobacco use” 
is defined as including cigarettes, cigars, pipes 
or any other tobacco products. “Current use” in-
cludes both daily and non-daily or occasional use. 
However, the definition applied in the source from 
which the data in this subsection were taken is not 
completely identical (tobacco “smoking” instead 
of tobacco “use” and in people aged 15 years and 
over instead of in people aged 18 years and over).
It should be noted that the data presented here 
are WHO estimates, and not official statistics 
reported by countries to WHO (10). WHO uses 
standard methods to calculate estimates to max-
imize cross-country comparability. These data 
Figure 2.2. Age-standardized mortality rate from all causes, all ages, deaths per 100 000 population
Source: Health for All database on the WHO European Health Information Gateway (9).
Note: The European regional average is calculated for those years when more than 26 countries (half of the 53 Member States) 
reported in that year. See Annex 2 for detailed notes.
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may therefore differ from the official statistics of 
Member States (10).
WHO estimates (based on data from 45 coun-
tries) show the age-standardized prevalence of 
current tobacco smoking among people aged 
15 years and above was 29% in 2013.
The prevalence of tobacco smoking in 2013 
among males (38.5%) was higher than that for 
females (20.7%). The highest and lowest nation-
al rates for smoking any tobacco product were 
59.8% and 18.6% among males and 39.7% and 
0.4% among females (see Fig. 2.3). These esti-
mates are the highest of the six Regions of WHO.
Figure 2.3. Age-standardized prevalence of current tobacco smoking among people aged 15 years 
and over (WHO estimates) (%), 2013
Source: Health for All database on the WHO European Health Information Gateway (9).
Note: Data unavailable for eight countries (AUT, CYP, MON, MNE, SMR, TJK, MKD, TKM).
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Prevalence of weekly tobacco use among 
adolescents: Large differences between 
countries, age groups and gender
Another additional indicator for this target is the 
prevalence of weekly tobacco use among adoles-
cents. “Tobacco use” includes cigarettes, cigars, 
pipes or any other oral tobacco and snuff prod-
ucts (1).
Data from the Health Behaviour in School-aged 
Children (HBSC) study have been used in this 
subsection.
According to that study (11), on average, only 
1.6% and 0.7% of male and female 11-year-olds in 
the Region reported in 2014 that they smoked at 
least once per week. However, the percentages in-
creased to 4.2% and 3.7% among male and female 
13-year-olds. These values varied between coun-
tries and between age groups (see Fig. 2.4–2.5).
Among 11-year-olds, the highest smoking rates 
in the Region were 9% for males and 2–3% for 
females, respectively, in Greenland and Israel (see 
Fig. 2.4), and the lowest smoking rates were 0% 
for both sexes in England, Finland, Greece, Ice-
land, the Netherlands, Scotland, Slovenia, Spain 
and Sweden (see Fig. 2.4).
Similarly, for 13-year-olds, the highest smoking 
rates in the Region were in Greenland: 15% for 
males and 25% for females (see Fig. 2.5), and the 
lowest smoking rates were 1% for males in Swe-
den and 0% for females in Norway and Armenia 
(see Fig. 2.5).
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Box 2.3. Health Behaviour in School-aged Children study
The Health Behaviour in School-aged Children (HBSC) is a  WHO collaborative cross-
national study which, for over 30 years, has collected data providing insight into European 
adolescents’ well-being, behaviour and social context. The survey began in three countries 
and is currently conducted in 42 countries, covering four out of every five Member States 
(79%) in the European Region. The latest international report, launched in 2016, remains the 
most downloaded report on the Regional Office’s website. Data from the HBSC is available 
via the European Health Information Gateway (https://gateway.euro.who.int/en/datasets/
hbsc/).
Country orientations organized by the WHO Regional Office for Europe, in coordination with 
the HBSC study centre, have increased regional momentum by connecting researchers with 
national stakeholders trying to collect systematic data to inform policies and programmes 
affecting adolescents. Armenia shared their experience of adopting the survey and their 
efforts to support adoption of the HBSC in central Asian countries in a recent story published 
online (13). Five countries are in the process of adopting the HBSC survey.
Yes
New member
In progress
No
Data not available
Latest data available 0 2300 46001150 KM
Member countries of Health Behaviour in School-aged Children (HBSC) in 2018
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Figure 2.4. Prevalence of weekly tobacco use among adolescents (proportion of young people who 
smoke at least once a week), 11 years old, by sex, 2014
Source: HBSC data on the WHO European Health Information Gateway (12).
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Figure 2.5. Prevalence of weekly tobacco use among adolescents (proportion of young people who 
smoke at least once a week), 13 years old, by sex, 2014
Source: HBSC data on the WHO European Health Information Gateway (12).
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Figure 2.6. Alcohol, heavy episodic drinking (population) past 30 days (%), age-standardized, 2010
Source: WHO Global Health Observatory (15).
Note: Data were not available for Monaco and San Marino in 2010.
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Heavy episodic drinking among 
adolescents varies greatly between 
countries in the Region
Another additional indicator for this target is 
the heavy episodic drinking (60 g  of pure alco-
hol or around six standard alcoholic drinks on at 
least one occasion weekly) among adolescents 
(15 years and over) (1).
However, due to data availability, WHO estimates 
(14) for heavy episodic alcohol drinking in the 
past 30 days have been used here. Accordingly, 
age-standardized heavy episodic drinking is de-
fined for the purposes of this subsection as the 
proportion of adults (aged 15 years and over) who 
have consumed at least 60 g of pure alcohol on at 
least one occasion in the past 30 days.
Reported values for heavy episodic alcohol drink-
ing in the past 30 days varied between countries 
in the Region in 2010 (see Fig. 2.6). The highest 
rates for both sexes were 38.5% in Austria and 
36.7% in Lithuania, and the lowest rates for both 
sexes were 0.2% and 1% in Turkey and Tajikistan 
(see Fig. 2.6).
In 2010, the national rates of heavy episodic drink-
ing (see Fig. 2.6) among males were higher than 
those for females. The highest and lowest nation-
al rates among males were 54.5% (Czechia) and 
0.3% (Turkey), respectively, in 2010 (see Fig. 2.6). 
The highest and lowest national rates among 
females were 24.3% (Lithuania) and 0% (Turkey), 
respectively, in 2010 (see Fig. 2.6).
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High variation in the levels of alcohol 
consumption between countries in the 
Region
The total (sum of recorded and unrecorded) 
adult per capita consumption of pure alcohol is 
the amount of alcohol consumed per adult (aged 
15  years and over) within a  calendar year, ex-
pressed in litres of pure alcohol (1).
In 2014, the regional average per capita alcohol 
consumption among people aged 15 and over 
within a calendar year was 8.6 litres of pure alco-
hol (see Fig. 2.7). This was only 3.4% lower than 
the reported baseline regional average in 2010 of 
8.9 litres per capita indicating that little progress 
is being made in this area.
Differences in the levels of alcohol consumption 
between countries in the Region remain large (see 
Map 2.1). The maximum and minimum reported 
national values slightly increased from 15 and 0.3 
litres per capita in 2010 to 15.2 and 1.1 litres per 
capita in 2014 (see Fig. 2.7).
Map 2.1. Recorded pure alcohol consumption among people aged 15 and over within a calendar year, 
litres per capita, latest available data
Source: Health for All database on the WHO European Health Information Gateway (9).
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High prevalence of overweight and 
obesity continues in the Region
This section describes the percentage of a  de-
fined population aged 18 years and over with over-
weight or obesity (defined as a BMI ≥25 kg/m2 for 
overweight and ≥30 kg/m2 for obesity) (1).
The prevalence of overweight and obesity has 
been steadily increasing in the WHO European 
Region over recent years (see Fig. 2.8–2.9). The 
rate increased from 55.9% in 2010 to 58.7% in 
2016 for overweight, and from 20.8% in 2010 to 
23.3% in 2016 for obesity (see Fig. 2.8–2.9).
The prevalence of overweight and obesity varies 
considerably between Member States in the Region 
(see Fig. 2.8–Fig. 2.9). In the 2000s, the difference 
between the highest and lowest rates for over-
weight and obesity in countries in the Region has 
been, on average, between 23.6 and 25 percentage 
points for overweight and between 15.1 and 16.7 
percentage points for obesity (see Fig. 2.8–2.9). In 
2010, however, the difference between the highest 
Figure 2.7. Recorded pure alcohol consumption among people aged 15 and over within a calendar 
year, litres per capita (litres of pure alcohol)
Source: Health for All database on the WHO European Health Information Gateway (9).
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and lowest rates for overweight in the Region was 
slightly reduced to 23.3 percentage points, and it 
was further reduced to 21.5 percentage points in 
2016 (see Fig. 2.8); the lowest rate in the Region 
was 45.3%, and the highest rate was 66.8% in 2016.
Yet, the opposite trend has been observed for 
obesity, as the difference between the highest and 
lowest rates in the Region had slightly increased 
to 16.9 percentage points in 2010, and further in-
creased to 17.9 percentage points in 2016 (see 
Fig. 2.9); the lowest rate in the Region was 14.2%, 
and the highest rate was 32.1% in 2016.
In 2016, the rates for overweight and obesity were 
63% and 21.9% among men and 54.3% and 24.5% 
among women. These rates were higher than the 
reported values in 2010: the rates for overweight 
and obesity were 59.7% and 18.8% among men 
and 52.1% and 22.5% among women. Overall, 
national-level data for 2016 showed that, in most 
countries in the European Region, overweight was 
more prevalent among men, while obesity was 
more prevalent among women.
Figure 2.8. Age-standardized prevalence of overweight (defined as BMI ≥25 kg/m2) in people 
aged 18 years and over, WHO estimates (%)
Source: Health for All database on the WHO European Health Information Gateway (9).
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Figure 2.9. Age-standardized prevalence of obesity (defined as BMI ≥ 30 kg/m2) in people 
aged 18 years and over, WHO estimates (%)
Source: Health for All database on the WHO European Health Information Gateway (9).
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Large differences in the prevalence of 
overweight and obesity among adolescents 
between countries, age groups and gender
An additional indicator for this Health 2020 tar-
get is the prevalence of overweight and obesity 
among adolescents (1) (defined as a BMI-for-age 
value above +1 Z-score and +2 Z-score3 relative 
to the 2007 WHO growth reference median (16)).
Data from the HBSC study (11) have been used 
here. The prevalence of overweight and obesi-
ty among young people (11, 13 and 15 years 
old) varied between countries, gender and age 
groups (see Fig.  2.10–2.12). According to the 
3	 The	Z-score	indicates	how	many	units	(of	the	standard	deviation)	a person’s	BMI	is	above	or	below	the	average	BMI	value	for	
their age group and sex.
study (11), in 2014, on average, nearly 17.5% 
and 26.8% of female and male 11-year-olds in 
the Region were overweight. The percentages 
were 15% and 23.4% among female and male 
13-year-olds. These values were lower for fe-
male (12.4%) and male (21.6%) 15-year-old 
adolescents.
In the three age groups (11, 13 and 15 years 
old), the highest prevalence of overweight in the 
Region was reported for Greenland, Greece, It-
aly and Malta, while young people (11, 13 and 
15 years old) in Denmark had one of the lowest 
reported prevalence of overweight and obesity 
in the Region (see Fig. 2.10–2.12).
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Box 2.4. FEEDCities Project – Eastern Europe and Central Asia
Unhealthy diet is major risk factor for noncommunicable diseases (NCDs). Salt, sugar 
and trans fatty acids (TFAs) are some of the dietary constituents connected with heart 
disease, cancer and diabetes. Urbanization and globalization of the food industry brought 
significant nutritional changes to the WHO European Region. These changes include a drop 
in the consumption of fibre and more frequent intake of processed foods, which are likely 
to contain more fats, sugar and salt and are known to be associated with weight gain 
and NCDs. More specifically, industrially produced TFAs and sodium heighten the risk for 
cardiovascular diseases. WHO is advocating complete elimination of TFAs from the global 
food supply and also calling for a significant reduction in sodium intake (most of it comes 
from salt and processed foods).
The WHO Regional Office for Europe launched the FEEDCities project to describe the street 
food environment and assess the food’s nutritional value in several capital cities in central 
Asia and eastern Europe. This innovative initiative aims to evaluate the presence of harmful 
components like trans fats and salt in common foods. This system for assessing the 
composition of foods sold in markets in central Asia and other eastern European countries 
has already been implemented in Tajikistan, Turkmenistan, Kazakhstan, Kyrgyzstan, 
Republic of Moldova and Bosnia and Herzegovina. Historically, street trade has been a well-
developed activity in this part of the world, with street food commonly sold in the central 
Asian bazaars; local dietary habits certainly reflect this. The project is based on a cross-
sectional evaluation of street food vending sites, including an analysis of food composition 
and the characterization of customers and items purchased, along with food product 
advertising in public spaces.
Bromatological analyses in all countries involved show that the quantities of sodium and 
TFAs in a single serving (i.e. the average portion usually sold) of some of the most readily 
available homemade and mass-produced foods far exceed the maximum recommended 
daily intake. WHO has jointly launched the results of the initiative in the countries involved 
and advised on actions to be taken. As a result, trans fat bans and other food regulations, 
notably limiting salt in food, are in the making. Where no national nutrition survey is currently 
available – this is the case for more than one third of the 53 Member States of the WHO 
European Region – FEEDCities can be adapted to serve as a valuable tool for data collection 
and monitoring of dietary habits. So far, the FEEDCities project has collected data on a vast 
array of topics, from geographical coordinates of street vendors to visual records (pictures 
and videos) and the dietary composition of food items, providing useful information for 
policy-makers and regulators for the first time in the involved countries.
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Box 2.5. Country profiles of child and adolescent health-related policies: 
Investing in children – the European child and adolescent health strategy 
(CAH) (2015–2020)
The strategy, which aims to “make children’s lives visible”, led to the development of country 
profiles that provide Member States with a view of the status of children and young people 
in their countries through indicators, including data from the Health Behaviour in School-
aged Children survey, directly linked to the strategy’s priorities. The profiles, available 
through the WHO European Health Information Gateway (12) were sent in 2016 to Member 
States with a complementary survey to capture the state of CAH and related policies in 
the Region since the strategy’s adoption. A  summary report presented to the Regional 
Committee in September 2018 highlights areas where the Region thrives and where there 
are gaps in policy. A final report on the strategy’s implementation will be presented in 2020. 
National survey findings led to the development of country feedback reports shared by 
the Regional Office with country representatives in the relevant country or during visits of 
country delegations to the WHO Regional Office for Europe. The feedback report provides 
country-specific achievements in CAH and possible areas for action. These tools support 
the regional commitment embedded in the strategy and the implementation of national 
programmes to achieve optimal health for European children and young people.
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Figure 2.10. Prevalence of overweight or obesity among adolescents, 11 years old, by sex
Source: HBSC data on the WHO European Health Information Gateway (12).
Pe
rc
en
ta
ge
Female Male
0
5
10
15
20
25
30
35
40
45
G
R
E
G
R
L
M
AT
M
K
D
IT
A
AR
M
SP
A
B
U
L
C
R
O
R
O
M
PO
L
H
U
N
PO
R
SV
N
R
U
S
SV
K
AL
B
ES
T
C
ZH
G
B
-S
CT LV
A
G
B
-W
LS
G
B
-E
N
G
LT
U
IS
R
LU
X
FI
N
IC
E
B
E-
W
AL
U
K
R
AU
T
FR
A
SW
E
D
EU
M
D
A
N
O
R
SW
I
B
E-
VL
G
N
ET
D
N
K
IR
E
30 European Health Report 2018
Figure 2.11. Prevalence of overweight or obesity among adolescents, 13 years old, by sex
Source: HBSC data on the WHO European Health Information Gateway (12).
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Figure 2.12. Prevalence of overweight or obesity among adolescents, 15 years old, by sex
Source: HBSC data on the WHO European Health Information Gateway (12).
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Summary of progress: Vaccine-
preventable diseases
High levels of child vaccination rates, 
yet cautious monitoring and compliance 
is needed
During the last decade, the average regional vac-
cination coverage rates increased or remained 
almost static for the three childhood vaccines 
against measles4, polio5 and rubella6.
Child immunization7 coverage has increased 
since the year 2000 to 94.3% and 96.1% for mea-
sles and polio, respectively, in 2015 (see Fig. 2.13). 
4 The percentage of children vaccinated against measles is the proportion of children reaching their second birthday who have been 
fully vaccinated against measles (one dose).
5	 The	percentage	of	infants	vaccinated	against	polio	is	the	proportion	of	infants	reaching	their	first	birthday	in	the	given	
calendar year who have been fully vaccinated against polio (three doses).
6 The percentage of infants vaccinated against rubella is the proportion of children reaching their second birthday in the given 
calendar year who have been fully vaccinated against rubella (one dose).
7 WHO stopped reporting separately on coverage for rubella vaccination in 2010, as nowadays rubella vaccination is always 
given in combination with vaccination for measles and mumps (MMR). Therefore, as of 2010, data on vaccination coverage 
for measles should be interpreted as vaccination coverage for measles and rubella.
These values are slightly higher than the reported 
baseline regional averages in 2010 of 92.2% for 
measles and 94.8% for polio.
Most recent data indicate that there were still con-
siderable differences in vaccination rates between 
countries, with some having vaccination rates be-
low 90%. In 2015, 10 countries had vaccination rates 
of less than 90% against measles, while five coun-
tries had vaccination rates of less than 90% against 
polio, leaving communities vulnerable to outbreaks.
Figure 2.13. Percentage of children vaccinated against measles and polio (%)
Source: Health for All database on the WHO European Health Information Gateway (9).
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Middle-income countries lagging 
behind in interrupting endemic measles 
and rubella transmission in the WHO 
European Region
The number of Member States in the WHO 
European Region that have interrupted measles 
since 2013 has doubled and progress against 
rubella elimination is also very promising (17). 
By the end of 2016, endemic measles and rubella 
transmission had been interrupted for more than 
12  months in 79% and 70% of the countries, 
respectively. While the WHO European Region 
as a  whole has made steady progress towards 
measles and rubella elimination in the last few 
years, stratifying the remaining endemic countries 
(nine for measles and 14 for rubella) by World 
Bank income level suggests that most of them 
are middle-income countries (Fig. 2.14).
Of the nine measles-endemic countries in the 
WHO European Region, six (67%) of them are mid-
dle-income countries, and of particular note, 55% 
of the measles-endemic countries in the Region 
are middle-income countries without any donor 
support. In 2015, 70% of the infants that did not 
receive the third dose of diphtheria–tetanus–per-
tussis vaccine resided in these middle-income 
countries without donor support. These countries 
in particular continue to face significant challeng-
es to the financial and operational sustainability 
of their immunization programmes. These factors 
contribute significantly towards a declining trend 
in vaccination coverage, including with the mea-
sles-containing vaccine, leading to susceptible 
pockets of the population that are not protected 
from measles and rubella. In order to achieve the 
measles and rubella target outlined in the Euro-
pean vaccine action plan 2015–2020 (18), it is 
essential that these middle-income countries 
develop context-specific, tailored immunization 
interventions.
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Figure 2.14. Measles elimination status in the WHO European Region, by World Bank 
income group, 2016
Source: Sixth meeting of the European regional verification commission for measles and rubella elimination (RVC) (17).
Note: For definition of high- and middle-income countries, see World Bank Country and Lending Groups (19).
HIGH-INCOME 
COUNTRY
n=32
Measles elimination 
status
Eliminated
Interrupted
Endemic
Verification process 
not initiated
MIDDLE-INCOME 
COUNTRY
With donor 
support
n=7
MIDDLE-INCOME 
COUNTRY
Without donor 
support
n=14
35European Health Report 2018
Box 2.6. Facing vocal vaccine deniers
Measles and rubella are highly contagious diseases. Therefore, at least 95% immunization 
coverage of each annual cohort is needed to achieve community protection and eliminate 
the diseases. Immunization coverage in the WHO European Region is generally high, 
however, among other challenges, the spread of misinformation about vaccines has 
resulted in a relatively low level of confidence in the safety of vaccines in some countries. 
This is a  serious concern that all immunization stakeholders must continue to address. 
Together with partners and Member States, the Regional Office for Europe works to build 
and maintain public confidence in vaccines and the authorities delivering them.
As part of this work, in 2017, the Regional Office further developed and refined a guidance 
document for health spokespersons facing vocal vaccine deniers (www.euro.who.int/
vaccinedeniers). The guide was originally developed based on a  review of peer-reviewed 
journal articles in the relevant fields, which revealed the five key topics and the five key 
techniques that are most commonly used by vaccine deniers, and presents a  set of 
appropriate responses that can be used to debunk the misperceptions of the denier and 
win over the attention and trust of the audience. The document includes sections on 
the psychological mechanisms of the target audiences, embracing techniques, religious 
concerns, addressing fake experts and unfavourable interview conditions.
The training programme developed for the area offers a variety of plenary presentations and 
case-based group work, placing particular emphasis on practical exercises and simulations 
of a  public debate with a  vocal vaccine denier. Subregional training workshops were 
conducted in 2017 for immunization programme managers from Albania, Austria, Bosnia 
and Herzegovina, Croatia, Germany, Montenegro and Serbia. A video from a December 2016 
training session was launched in 2017 and is available online (20).
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Box 2.7. Addressing health inequality through tailored immunization 
services
Closing immunization gaps and equitably extending the benefits of vaccination to all are 
crucial if the Region is to meet the goals of eliminating measles and rubella and maintaining 
the polio-free status it has enjoyed since 2002. The reasons for insufficient coverage differ 
per country and are diverse within each country, often including both supply challenges 
and insufficient uptake of offered vaccines. To address the latter it is imperative for health 
authorities to understand the factors influencing vaccination intentions, decisions and 
behaviours.
The WHO Regional Office for Europe developed a Guide to tailoring immunization programmes 
(TIP) in 2014 in response to this need. Based on experience in several countries and an 
external review conducted in 2016, the approach was refined in 2017. It provides a logical 
pathway for all TIP projects, including a structured process from initial data collection and 
analysis to intervention planning, implementation and evaluation.
To build capacity for implementing the approach, the WHO Regional Office for Europe, in 
collaboration with the University of Erfurt, Germany, organized a  one-week Behavioural 
Insights Summer School in September 2017 with participation from PhD students and 
immunization programme managers and staff from Bosnia and Herzegovina, France, 
Finland, Germany, Republic of Moldova, Serbia and Sweden.
TIP projects are currently underway in Armenia, Bosnia and Herzegovina, and Serbia, focusing 
in part on identifying health workers’ barriers and needs, and in Romania, where a  rapid 
survey was conducted to understand the barriers to vaccination among families affected by 
measles. A peer-reviewed publication on the external review results and recommendations 
was published in the journal Vaccine (21).
Summary of progress: Mortality from 
external causes
Steady decline in death rates from all 
external causes, including injuries and 
poisoning
In 2015, deaths due to external causes, includ-
ing injuries and poisoning, constituted the third 
leading cause of death in Europe, accounting for 
7% of all deaths, after diseases of the circulatory 
system (44%) and malignant neoplasms (21%). 
The regional average age-standardized death 
rate from external causes consistently decreased 
from 82  deaths per 100  000 in 2000 to 57 per 
100 000 in 2010 and 50 per 100 000 in 2015 (see 
Fig. 2.15). Still, there were very wide inequalities 
in the death rates between the sexes, and across 
countries. The regional average death rate among 
males was 3.5 and 3.3 times higher than for 
females in 2010 and 2015, respectively.
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The differences in death rates from all external 
causes between countries have decreased con-
siderably over time. The gap between the highest 
and lowest death rates in the Region has nar-
rowed from 118 deaths per 100  000 in 2010 to 
73 per 100 000 in 2015 though recent values for 
2015 indicate that the remaining differences be-
tween countries are still large. In 2015, the highest 
rate in the Region was 95 deaths per 100 000 and 
the lowest 22 per 100 000, yet only 27 countries 
reported data for 2015.
There are six additional indicators linked to this 
core indicator: motor vehicle traffic accidents; 
accidental falls; accidental poisoning; acciden-
tal poisoning by alcohol; suicide and intentional 
self-harm; and homicide and assault. This sub-
section examines the pattern and trend of deaths 
by cause for the period between 2000 and 2015 
(see Fig. 2.16).
Suicide and self-inflicted injury, along with motor 
vehicle traffic accidents, were the leading external 
causes of death in 2014 (21% and 15%, respec-
tively, of all external causes of death and injury 
combined). In 2015, suicide and self-inflicted in-
jury was the leading external cause of death (con-
stituting 21% of all external causes of death and 
injury combined).
Moreover, over the same period, there was a wide 
variation between countries for each separate 
cause.
To conclude, in 2015, deaths due to external causes 
were the third leading cause of death in the Region, 
accounting for 7% of all deaths, which continues to 
represent a  major public health problem. Despite 
an overall decline in associated trends over recent 
decades, there were wide differences in death rates 
between the sexes and countries in the Region.
Figure 2.15. Standardized death rates from all external causes, including injuries and poisoning, 
overall and by sex
Source: Health for All database on the WHO European Health Information Gateway (9).
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Figure 2.16. Regional average standardized death rates from external causes, by cause
Source: Health for All database on the WHO European Health Information Gateway (9).
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Target 2.  
Increase life expectancy in Europe
Box 2.8. Health 2020 Target 2 and indicators
Target 2 “Increase life expectancy in Europe” is linked to Health 2020 policy area 2 “Healthy 
people, well-being and determinants”.
The quantification for this Health 2020 target is a continued increase in life expectancy at the 
current rate (the annual rate for the period 2006–2010), coupled with reducing differences 
in life expectancy in the Region.
The core indicator for this target is life expectancy at birth.
There are two additional indicators for this target: quantification of life expectancy at ages 
1, 15, 45 and 65 years, and healthy life years at age 65.
Introduction
The regional average life expectancy has stead-
ily increased over recent years and the gaps in 
average life expectancy between the sexes and 
between countries are getting narrower. However, 
there are still considerable differences which re-
quire continued monitoring to ascertain consist-
ent improvement. In 2015, the difference between 
countries with the highest life expectancy and the 
lowest was more than a decade. Women still live 
longer than men at all ages.
Despite increase in life expectancy 
at birth, the difference between 
countries with the highest and lowest 
life expectancy in the Region is still 
more than a decade
The aim for this Health 2020 target is to increase 
overall life expectancy while reducing differences 
in life expectancy between countries (1).
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According to the WHO definition, life expectan-
cy at birth is the average number of years that 
a newborn is expected to live if current mortality 
rates continue to apply.
The regional average life expectancy has stead-
ily increased over recent decades. Average life 
expectancy at birth in the European Region in-
creased from 76.7 years in 2010 to 77.9 years in 
2015 (see Fig. 2.17) which represented an aver-
age annual increase of 0.24 years. This increase 
is in line with the Health 2020 target.
The difference between the highest and lowest 
life expectancy in the Region is decreasing (see 
Fig. 2.17); it was 16.8 years in 2000, 14.2 years in 
2010 and 11.5 years in 2015. In 2015, the lowest 
value in the Region was 71.6 years, while the high-
est was 83.1 years.
Figure 2.17. Life expectancy at birth (years)
Source: Health for All database on the WHO European Health Information Gateway (9).
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Figure 2.18. Male and female life expectancy at birth (years)
Source: Health for All database on the WHO European Health Information Gateway (9).
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Considering gender differences, life expectancy 
at birth in the WHO European Region in 2015 was 
74.6 years for males and 81.2 years for females 
(see Fig. 2.18). These values show an increase of 
approximately 1.3 years for males and 1.0 years 
for females since 2010.
The gender gap in life expectancy continues to de-
crease over time. It fell from 7.7 years in 2000, to 
6.9 years in 2010 and 6.6 years in 2015.
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The narrowing gaps in regional averages of life ex-
pectancy between the sexes and between coun-
tries are encouraging. However, the remaining dif-
ferences are still large and continued monitoring 
is required to ascertain consistent improvement.
Continuous increase in life expectancy 
at ages 1, 15, 45 and 65 years
An additional indicator for this Health 2020 target 
is life expectancy at ages 1, 15, 45 and 65 years 
(see Fig. 2.19) (1).
Overall, people are living longer in the Region. In 
2015, on average, a  person in the Region is ex-
pected to live for 77.3 years at age 1, 63.5 years 
at age 15, 35.1 years at age 45, and 18.5 years 
at age 65. This is an increase on the correspond-
ing values reported in 2010: 76.2 years at age 1, 
62.5  years at age 15, 34.2 years at age 45, and 
17.9 years at age 65.
Table 2.1 shows the regional average life expec-
tancy (years) at ages 1, 15, 45, and 65 years for 
both sexes over time. Females still live longer 
than males (see Table 2.1).
Figure 2.19. Regional average life expectancy (years) at ages 1, 15, 45 and 65 years
Source: Health for All database on the WHO European Health Information Gateway (9).
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The data in Table 2.1 indicate that the gender gap 
reduced slightly between 2010 and 2015 for re-
gional average life expectancy at ages, 1, 15 and 
45. However, it increased slightly for regional av-
erage life expectancy at 65 years old.
Moreover, there are still differences between 
countries in life expectancy at ages 1, 15, 45 and 
65 years.
Table 2.1. Regional average life expectancy (years) at ages 1, 15, 45 and 65 years, by sex
Year
Life expectancy 
at age 1
Life expectancy 
at age 15
Life expectancy 
at age 45
Life expectancy 
at age 65
Female Male Female Male Female Male Female Male
2000 77.5 69.9 63.9 56.3 35.1 29.1 17.9 14.3
2001 77.7 70.2 64.0 56.5 35.3 29.3 18.1 14.6
2002 77.7 70.2 64.0 56.5 35.2 29.3 18.0 14.5
2003 77.6 70.2 63.9 56.6 35.1 29.3 17.9 14.5
2004 78.1 70.7 64.4 57.0 35.6 29.7 18.4 14.9
2005 78.1 70.8 64.4 57.1 35.6 29.7 18.4 14.9
2006 78.6 71.4 64.9 57.7 36.0 30.3 18.8 15.3
2007 78.9 71.7 65.1 58.0 36.3 30.5 18.9 15.4
2008 79.1 72.0 65.3 58.3 36.4 30.7 19.1 15.6
2009 79.4 72.5 65.6 58.7 36.7 31.0 19.3 15.7
2010 79.6 72.8 65.8 59.1 36.9 31.3 19.4 15.9
2011 80.0 73.2 66.2 59.5 37.2 31.6 19.7 16.1
2012 80.2 73.6 66.4 59.9 37.4 31.9 19.8 16.3
2013 80.4 73.8 66.6 60.1 37.6 32.1 20.0 16.4
2014 80.7 74.1 66.8 60.3 37.8 32.3 20.1 16.6
2015 80.6 74.1 66.8 60.3 37.7 32.3 20.1 16.5
Source: Health for All database on the WHO European Health Information Gateway (9).
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Healthy ageing: Increments in healthy 
life years at age 65
Another additional indicator for this target is 
healthy life years (HLY) at age 65, disaggregated 
by sex. This indicator (also called disability-free 
life expectancy) measures the number of years 
that a person at age 65 is still expected to live in 
a healthy condition (1). It is calculated separately 
for males and females (1).
The HLY indicator has been used to describe, 
monitor and improve the health status and qual-
ity of life of elderly populations over time (22). 
Assessment of life expectancy, mortality rates 
and HLY enable policy-makers and concerned 
stakeholders to determine whether populations 
are living longer healthy lives or not.
As already discussed, death rates have declined 
and the corresponding values for life expectancy 
have increased over recent decades. According to 
Eurostat data, between 2010 and 2015, the aver-
age HLY for EU countries increased from 8.8 years 
to 9.4 years for females and from 8.7 to 9.4 years 
for males. In 2015, the HLY varied significantly by 
geographical boundaries or country in the EEA/
EFTA countries (see Fig. 2.20). In the same year, 
at 65 years of age, HLY for Swedish females was 
16.8 years, 1.1 years greater than that for males 
at 15.7 years. These values were much higher 
than the reported values for Slovakian females 
(3.8 years) and Slovakian males (4.1 years), which 
were the lowest reported values in the EEA/EFTA 
countries in 2015 (see Fig. 2.20).
Figure 2.20. Healthy life years at age 65, by sex, 2015
Source: Eurostat (23).
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Target 3.  
Reduce inequalities in health in Europe 
(social determinants target)
Introduction
The inequalities in infant mortality between coun-
tries and gender have been declining over recent 
decades.
The Region has experienced a noticeable reduction 
in infant mortality rates since 2000 but differences 
still exist between countries.
Since 2000, the Region has made progress in the 
proportion of children of official primary school 
age that are enrolled in school but there was also 
a  large variation between countries regarding 
the proportion of children not enrolled in primary 
school.
Differences between countries in the Region in un-
employment rates have been decreasing. Never-
theless, there is a wide variation between countries. 
Out of the 53 countries in the WHO European Re-
gion, the number of countries that have implement-
ed a policy or strategy to address inequality or so-
cial determinants has increased since 2010 and the 
regional average of income inequality as expressed 
by the Gini coefficient has decreased. At the same 
time, there were large differences in levels of income 
inequality between the countries in the Region.
Such inequalities have significant humanitari-
an, health and economic implications. To narrow 
these gaps, current collaborative efforts across 
all relevant sectors and stakeholders need to be 
strengthened.
Box 2.9. Health 2020 Target 3 and indicators
All citizens have the right to good health, well-being, education and equal opportunities to 
prosper where they live.
Target 3 “Reduce inequalities in health in Europe (social determinants target)” is linked to 
Health 2020 policy area 2 “Healthy people, well-being and determinants”. The target is to 
achieve a  reduction in the gaps in health status associated with social determinants in 
Europe (1). This target has five key indicators:
• Infant mortality per 1000 live births
• Proportion of children of official primary school age not enrolled
• Unemployment rate
• National and/or subnational policy addressing the reduction of health inequality 
established and documented
• Gini coefficient (income distribution).
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Decline in inequality in infant 
mortality between countries and 
gender
The infant mortality rate is the probability that 
a  child born in a  specific year or period will die 
before reaching the age of 1 year, if subject to 
age-specific mortality rates of that period, ex-
pressed as a rate per 1000 live births (1). Reduc-
tion of infant mortality rates is one of the main 
health targets of the SDGs. Overall, the Region is 
on track to reach SDG Target 3.2 (24) which aims 
to “end preventable deaths of newborns and chil-
dren under 5 years of age, with all countries aim-
ing to reduce neonatal mortality to at least as low 
as 12 per 1000 live births and under-5 mortality to 
at least as low as 25 per 1000 live births” by 2030.
The WHO European Region has made gains in 
closing the gaps in infant mortality between coun-
tries and between the sexes. In 2015, the regional 
average infant mortality was 6.8 infant deaths per 
1000 live births (see Fig. 2.21), which was lower 
than the reported rate in 2000 (9.9 infant deaths 
per 1000 live births) and 2010 (7.3 infant deaths 
per 1000 live births), representing an average an-
nual decline of 1.4% since 2010.
In 2015, the regional average infant mortality 
rate for males was 7.3 infant deaths per 1000 
live births and the rate for females was 5.9; both 
have steadily decreased since 2000, from 11.1 
for males and 8.8 for females. The most recent 
figures showed a decline of 9.9% for males and 
10.6% for females since 2010, from 8.1 deaths 
per 1000 live births for males and 6.6 for females.
The difference between the highest and lowest 
infant mortality rates in the Region is decreasing 
(see Fig. 2.21): 23.0 infant deaths per 1000 live 
births in 2000; 20.1 in 2010; and 20.5 in 2015. The 
lowest and highest infant mortality rates in the 
Region were 1.6 and 22.1 deaths per 1000 births, 
respectively, in 2015 (see Fig. 2.21). Caution is 
needed, however, in interpreting the trends, as 
only 29 countries reported data for 2015.
Figure 2.21. Infant deaths per 1000 live births
Source: Health for All database on the WHO European Health Information Gateway (9).
Note: The maximum regional value in the infant mortality rate is a reflection of the infant mortality rate in Kyrgyzstan. The sharp increase 
since 2004 is an artefact of the introduction of the WHO definition for live births and stillbirths in Kyrgyzstan (25, 26).
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Differences still exist between 
countries in the Region in the 
proportion of children not enrolled 
in primary school
This indicator is defined as the number of children 
of official primary school age who are not enrolled 
in primary school  – which is expressed as a  per-
centage of the population of official primary school 
age (1). Children enrolled in pre-primary education 
are excluded and considered to be out of school (1).
Since 2000, the regional average proportion of 
children of official primary school age not enrolled 
has declined (see Fig. 2.22). It decreased from 
3.1% in 2000 to 2.6% in 2010 and 2.3% in 2015. 
The regional average proportion of boys not en-
rolled in 2000 was 3.3%, and for girls, 3.9%, which 
deceased to 2.8 for both boys and girls in 2010 
and to 2.7% for boys and 2.5% for girls in 2015.
The difference between the maximum and mini-
mum proportions of children of official primary 
school age not enrolled in school has decreased 
from 15.2 percentage points in 2010 to 10.0 per-
centage points in 2015 (see Fig. 2.22). Recent 
data, however, indicate that there is a  large vari-
ation between countries. In 2015, the maximum 
reported proportion in the Region was 10.1% while 
the minimum was 0.1% (see Fig. 2.22).
Figure 2.22. Proportions of children of primary school age not enrolled (%)
Source: Health for All database on the WHO European Health Information Gateway (9).
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Differences in unemployment rates 
are decreasing, but a wide variation 
still exists between countries in the 
Region
Unemployment rates contribute to the measure-
ment of the target of reducing inequality. The 
unemployed comprise all people of working 
age who were: a) without work during the refer-
ence period (i.e. were not in paid employment 
or self-employment); b) currently available for 
work (i.e. were available for paid employment or 
self-employment during the reference period); 
and c) seeking work (i.e. had taken specific steps 
in a specified recent period to seek paid employ-
ment or self-employment) (1).
The WHO European regional average unemploy-
ment rate (see Fig. 2.23) decreased to 8.7% in 
2015, which was slightly lower than the regional 
average for 2010 (8.9%), yet slightly higher than 
the reported rate for 2000 (8.4%).
There was wide variation in the unemployment 
rates across the Region in 2015, which ranged 
from a  minimum value of 0.5% to a  maximum 
value of 26.1%. The differences between the 
maximum and minimum unemployment rates 
have been decreasing over the last decade: from 
31.3  percentage points in 2010 to 25.6 percent-
age points in 2015 (see Fig. 2.23).
Figure 2.23. Unemployment rate (%)
Source: Health for All database on the WHO European Health Information Gateway (9).
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Policies to tackle health inequities in 
place in 42 countries in 2016
Health inequities are unfair distributions of 
health and well-being outcomes (1). Social de-
terminants of health include all political, social, 
economic, institutional and environmental fac-
tors which shape the conditions of daily life (1), 
contribute to health and well-being and the onset 
of illness throughout a person’s life. National pol-
icies that address the reduction of health inequi-
ties by taking action on the social determinants 
of health can lead to improvements in the overall 
health and well-being of the entire population.
The number of countries in the European Re-
gion establishing and documenting national and 
subnational policies to address the reduction of 
health inequities has been increasing (see Fig. 
2.24). In 2016, 42 countries out of 53 (79%) had 
a  policy or strategy in place to address inequi-
ties or social determinants. This is an increase 
from 29 and 35 countries, respectively, in 2010 
and 2013.
Figure 2.24. All country replies on the existence of a national or subnational policy or strategy 
addressing health inequities or social determinants of health (2010: n = 33; 2013: n = 40; 
2016: n = 43)
Source: WHO Regional Office for Europe (27).
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Decline in inequalities in income 
distribution between the countries 
in the Region
The Gini coefficient measures the extent to which 
the distribution of income (or, in some cases, 
consumption expenditure) among individuals or 
households within an economy deviates from 
a perfectly equal distribution (1).
The WHO European regional average of income 
inequality (Gini coefficient) has slightly decreased 
over the last decade from 34.3 in 2004 to 33.7 in 
2015, respectively.
At the same time, there were large differences 
in levels of income inequality between the coun-
tries in the Region which ranged from a minimum 
value of 23.6 to a maximum value of 38.2 in 2015 
(see Fig. 2.25). The differences between the max-
imum and minimum values in the Region have 
been slowly decreasing over recent years (see 
Fig. 2.25): from 19.9 percentage points in 2010 
to 17.4 percentage points in 2014 and 14.6 in 
2015, representing a decrease of 27% since 2010. 
However, these trends should be interpreted with 
caution as the number of countries that reported 
data decreased from 40 countries in 2010 to 37 in 
2014 and 31 countries in 2015.
Figure 2.25. Gini coefficient (income distribution)
Source: Health for All database on the WHO European Health Information Gateway (9).
Note: The European regional average is calculated for those years when more than 26 countries (half of the 53 Member States) 
reported in that year. See Annex 2 for detailed notes.
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Introduction
The assessment of well-being as a  multidimen-
sional concept is a core target area in Health 2020 
policy for the Region. Reporting on well-being indi-
cators within the Health 2020 framework informs 
stakeholders about the distribution of well-being 
across different population groups as well as the 
drivers and barriers to well-being (28).
The WHO European Region’s overall life sat-
isfaction index is 6. However, some countries 
have a  relatively low life satisfaction score of 5 
or below, while other countries have the highest 
scores in the world.
The indicator of social support (one of the objec-
tive well-being indicators), is high in the Region 
with 81% of the population aged 50 years and 
above reporting that they had relatives or friends 
on whom they could count when in trouble. How-
ever, this is lower than the reported value for 2013. 
There was a  large variation between different 
countries in the Region, reflecting a  gradient of 
social connectedness across the Member States.
Concerning the second indicator on objective 
well-being, in 2015, more than 90% of the popula-
tion in the Region had access to improved sanita-
tion facilities and piped drinking water. Yet there 
were inequalities in access between the urban 
and rural areas in the Region.
In 2015, on average, the percentage of the adult 
population that had completed at least secondary 
education remained almost unchanged. However, 
educational attainment varied between countries 
in the Region.
According to the Eurostat database which in-
cludes data on 34 countries in the Region, the per-
centage of people aged 65 years and above that 
live alone has increased, with women consti tuting 
the greater share of older adults living alone. 
Finally, there has been a  steady increase in the 
regional average of household final consumption 
expenditure per capita which is now the highest 
reported since 2000, the reference year.
These findings revealed a  diverse performance 
of Member States in relation to their populations’ 
well-being. Improved well-being contributes to 
better mental and physical health, higher pro-
ductivity at work and in turn stronger economies. 
Hence, careful design, monitoring and implemen-
tation of well-being policies and strategies will 
need to continue in the Region.
Target 4.  
Enhance the well-being of the European population
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Box 2.10. Health 2020 Target 4 and indicators
Well-being is both subjective and objective. It comprises an individual’s experience of their 
life as well as a comparison of life circumstances with social norms and values.
Target 4 “Enhance the well-being of the European population” is linked to Health 2020 policy 
area 2 “Healthy people, well-being and determinants”. The quantification for this target is 
set as a result of the baseline of the core well-being indicators.
The indicator for subjective well-being is life satisfaction and those for objective well-being 
include:
• availability of social support
• percentage of population with improved sanitation facilities
• Gini coefficient (described in the section on Target 3)
• unemployment rate (described in the section on Target 3), and
• proportion of children of official primary school age not enrolled in school (described in 
the section on Target 3).
The additional indicators include:
• percentage of people aged 65 years and over living alone
• household final consumption expenditure per capita, and
• educational attainment of people aged 25 years and over who have completed at least 
secondary education.
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Subjective well-being: average level of 
life satisfaction in the Region
Life satisfaction comprises the subjective dimen-
sion of well-being in Health 2020 (1). The life sat-
isfaction score is measured on a scale from zero 
(least satisfied) to 10 (most satisfied) for the ques-
tion: “How satisfied are you with life these days?”
Data from the Gallup World Poll for 2014–2015, 
obtained through the United Nations Development 
Programme’s Human Development Report 2016 
(29), give the WHO European Region an overall life 
satisfaction score of 5.9. Data were available for 
50 countries in the Region.
There is considerable variation in life satisfaction 
levels between the countries in the Region. Some 
countries have a  relatively low overall average 
self-reported life satisfaction score, with aver-
age scores of 4.9 or below. Other countries in the 
Region have higher scores of up to 7.6 (which is 
also the highest score in the world) (29). Twen-
ty-three countries have an average life satisfac-
tion score above 6; the remaining 27 have a score 
of 5.9 or lower (see Fig. 2.26).
Figure 2.26. Overall life satisfaction in the WHO European Region, 2014–2015
Source: adapted from  (29).
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High level of social connectedness in 
the Region: 81% of the population has 
social support through family or friends
Social connectedness is a  measure of objec-
tive well-being (1). Its importance for health 
and well-being has been well established and 
is therefore a  common element in well-being 
frameworks (1).
The level of availability of social support (objec-
tive well-being indicator) is expressed as a per-
centage of the population aged 50 years and 
above who responded “yes” to the survey ques-
tion: “If you were in trouble, do you have relatives 
or friends you can count on to help you when-
ever you need them, or not?” (1). In 2015, 81% 
responded positively. This average percentage is 
slightly lower than that reported in 2013 (86%).
There is a  large gap between the countries in 
the Region reporting the highest and lowest 
proportions of social connectedness which 
ranged from 43% to 95% in 2015. In 2015, 64% 
of countries in the Region had a  proportion of 
social connectedness of 80% or higher, while for 
13% of countries the proportion was below 70% 
(Fig. 2.27).
Figure 2.27. Percentage of people aged over 50 years who have social support, proportion of 
countries, 2015
Source: Health for All database on the WHO European Health Information Gateway (9).
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Inequalities in rural and urban access 
to piped water and sanitation systems 
persist
An improved sanitation facility is defined as one 
that hygienically separates human excreta from 
human contact (1). Living in satisfactory and san-
itary housing conditions is one of the most impor-
tant aspects of people’s lives (1). An assessment 
of population well-being thus needs to examine 
living conditions and whether dwellings have 
access to facilities – including an adequate water 
supply and sewage system – that are considered 
basic needs and human rights (1).
Improved sanitation facilities include flush toilets 
(alternatively pour flush to piped sewer system, 
septic tank, or pit latrine); ventilated improved pit 
latrines; pit latrines with slab; and composting 
toilets (1).
Using the pre-specified definition by the WHO/
UNICEF Joint Monitoring Programme for 
Water Supply and Sanitation, more than 90% 
of the  population in the Region has access to 
improved sanitation facilities and piped drinking 
water (see Fig. 2.28–2.30).
Figure 2.28. Access to piped water in urban and rural areas
Source: Health for All database on the WHO European Health Information Gateway (9).
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In 2015, 97.9% of the population in the WHO Euro-
pean Region had access to piped drinking water: 
96.3% of the population in rural areas and 99.3% 
of the population in urban areas (see Fig. 2.28). 
These average proportions show a small increase 
since 2010 when the percentages were 95.2% for 
rural areas and 99.2% for urban areas. In 2015, 
there were large inequalities in access to piped 
drinking water between the urban and rural areas 
in the Region, which ranged from 93.1% to 100% 
for populations in urban areas and from 66.7% 
to 100% for populations in rural areas.
In 2015, 92.9% of the population in the WHO 
European Region had access to improved sanita-
tion systems. By 2015, 89.2% of the population in 
rural areas and 94.6% of the population in urban 
areas had access to a  sewage system, septic 
tank or other hygienic means of sewage disposal. 
These proportions show a  small improvement 
since 2010 when the percentages were 88.2% for 
rural areas and 94.4% for urban areas.
The proportion of the rural population with access 
to improved sanitation facilities in 2015 was be-
low 85% in nine countries and below 70% in three 
(see Fig.  2.29). In urban areas it was below 90% 
in five countries and below 80% in one country 
(see Fig. 2.30).
These figures show that the Region still lags behind 
the targets for SDG goals (24). SDG Targets 6.1 
and 6.2 aspire to “achieve universal and equitable 
access to safe and affordable drinking water for 
all; and achieve access to adequate and equitable 
sanitation and hygiene for all”.
Figure 2.29. Number of countries in which the proportion of the rural population with access to 
improved sanitation facilities is below 100%, 85% or 70%
Source: Health for All database on the WHO European Health Information Gateway (9).
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Highest level of household final 
consumption expenditure per capita 
since 2000: US$ 15 120 in 2016
Household final consumption expenditure is 
the market value of all goods and services, 
including durable products (such as cars, washing 
machines and home computers), purchased by 
households (1). It excludes purchases of dwellings 
but includes imputed rent for owner-occupied 
dwellings (1). It also includes payments and fees 
to governments to obtain permits and licenses (1). 
There has been a steady increase in the regional 
household final consumption expenditure per 
capita (constant 2010 US$); it increased from US$ 
12 902 in 2010 to US$ 15 120 in 2016, which is the 
highest reported since 2000, the reference year 
(see Fig. 2.31).
Figure 2.30. Number of countries in which the proportion of the urban population with access to 
improved sanitation facilities is below 100%, 90% or 80%
Source: Health for All database on the WHO European Health Information Gateway (9).
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Figure 2.31. Household final consumption expenditure per capita (constant 2010 US$), latest 
available year
Source: World Bank (30).
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Large differences between countries 
in the Region in educational 
attainment of people aged 25 years 
and above who have completed at 
least secondary education
Educational attainment is defined as the highest 
level successfully completed in the educational 
system of the country where the education was 
received (1). The levels of education are defined 
according to the International Standard Classifi-
cation of Education (ISCED) of 1997 (1).
According to UNESCO data, on average, the 
percentage of the adult population who had 
completed at least secondary education (ISCED 
level  2 and up) remained unchanged between 
2010 (51.2%) and 2015 (50.0%); 32 countries in 
the Region reported data (see Fig. 2.32).
There are large differences between countries in 
educational attainment of people aged 25 and 
above who have completed at least secondary 
education; in 2015, the maximum reported 
value in the Region was 80.3% and the minimum 
reported value was 34%.
Figure 2.32. Percentage of people aged 25 years and above who have completed at least secondary 
education
Source: UNESCO (31).
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A high percentage of people aged 
65 years and above live alone
This indicator measures the potential support 
needed for older  – and in general more 
vulnerable – people in a community by measuring 
the percentage of people aged 65 and over that 
live alone (1).
The percentage of people aged over 65 who live 
alone has increased from 29.9% in 2010 to 30.9% 
in 2016 (see Fig. 2.33), according to the Eurostat 
database, which includes data on 34 countries in 
the Region.
In 2010, women made up a greater share of old-
er adults living alone as 38.7% of elderly women 
were living alone. Since then, the percentage of 
older women living alone has slightly increased 
to 39.2% in 2016, while the percentage of older 
men living alone has risen from 18.3% in 2010 to 
20.2% in 2016. The gender difference is largely 
a reflection of the gap in life expectancy between 
men and women.
Figure 2.33. Percentage of people aged 65 years and above living alone, by sex
Source: Eurostat (23).
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Target 5.  
Ensure universal coverage and the “right to health”
Introduction
Target 5 is focused on achieving universal health 
coverage by 2020 and envisages the “right to 
health” as a core policy construct and vision that 
fosters the idea that provision of equitable fair ac-
cess to effective and needed services without fi-
nancial burden is a fundamental right of all citizens.
The WHO Director-General, Dr Tedros, identified 
universal health coverage as one of the five key 
priorities for the World Health Organization (32). 
Ensuring universal health coverage without im-
poverishment is the foundation for achieving the 
health objectives of the SDGs (32). The World 
Health Assembly made universal health cover-
age one of WHO’s three strategic priorities in the 
WHO’s thirteenth general programme of work 
2019–2023, by setting the strategic priority (and 
goal) of “reducing persistent barriers to access-
ing health services and 1 billion more people 
benefitting from universal health coverage” (33).
Moreover, achieving universal health coverage 
will put the health system into a better position 
to respond to new and intensifying challenges, 
such as antibiotic resistance. Antibiotic resist-
ance leads to longer hospital stays, higher med-
ical costs and increased mortality. A  sustained 
response to antibiotic resistance will address 
these (34).
Countries should secure sufficient resources to 
support universal health coverage systems in 
which essential health services are available to 
all individuals who need them while at the same 
time reducing out-of-pocket payments.
Member States’ performance is showing a mixed 
picture in association with the indicators for Tar-
get 5. The WHO European regional average total 
health expenditure as a percentage of GDP has 
remained unchanged since 2010. Likewise, the 
regional average of the general government ex-
penditure on health as a percentage of GDP has 
also remained unchanged. There are, however, 
large differences in levels of public expenditure 
on health between the countries in the Region. 
Private household out-of-pocket expenditures as 
a share of total expenditure on health has slightly 
increased with great variation across the Region.
On the other hand, the WHO European Region 
has made some gains in closing the gap in ma-
ternal mortality which decreased between 2010 
and 2015.
Similarly, the regional average treatment success 
rate (%) for new pulmonary TB cases has also im-
proved slightly over the last decade. There were, 
however, large differences in reported treatment 
success rates by the Member States.
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Box 2.11. Health 2020 Target 5 and indicators
Target 5 is “moving towards universal coverage (according to the WHO definition: Equitable 
access to effective and needed services without financial burden) by 2020”. To assess 
countries’ performance in relation to this target, Member States in the Region collect and 
report data for a set of core indicators:
• private household out-of-pocket payments as a proportion of total health expenditure 
(WHO estimate)
• percentage of children vaccinated against measles, polio and rubella (described in the 
section on Target 1)
• total expenditure on health (as a percentage of GDP) (WHO estimate).
The additional indicators include:
• maternal deaths per 100 000 live births
• percentage of people treated successfully among laboratory-confirmed (new smear-
positive) pulmonary tuberculosis cases who completed treatment
• government (public) expenditure on health as a percentage of GDP (WHO estimate).
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Box 2.12. Surveillance of antibiotic resistance in the European Region
Surveillance is an essential tool for assessing the sources and trends of antibiotic resistance, 
informing policies and interventions and monitoring their impact. In many EU/EEA countries, 
surveillance of antibiotic resistance has been performed for almost two decades, which has 
been coordinated by the European Centre for Disease Prevention and Control since 2010 as 
the European Antimicrobial Resistance Surveillance Network (EARS-Net). In 2012, the Regional 
Office, together with partners, established the Central Asian and Eastern European Surveillance 
of Antimicrobial Resistance (CAESAR) network to assist countries in the rest of the European 
Region to set up or strengthen national surveillance systems to complete the regional overview 
of antibiotic resistance. In some countries, this proved particularly difficult since antibiotic 
susceptibility testing of samples obtained from patients to support treatment decisions was not 
done routinely, so data on antibiotic resistance were not readily available. To stimulate routine 
sampling practice to improve patient treatment (antibiotic stewardship) and enable national 
antimicrobial resistance surveillance, a so-called proof-of-principle (PoP) study was designed. 
Such a  study entails selecting project hospitals, forming interdisciplinary hospital teams, 
providing criteria for sampling patients, training hospital and national reference laboratory 
personnel on international diagnostic standards and setting up lines of communication for 
results and project progress within and between project teams.
The first PoP study was performed in Georgia between July 2015 and December 2016. At the 
end of the study, a stakeholder meeting was organized in May 2017 to discuss the obtained 
data with the participating hospitals, the lessons learnt and the next steps needed at the 
hospital and the national level to ensure sustainable implementation. The results presented 
during the stakeholder meeting indicated that the study had successfully demonstrated the 
value of standardizing blood culturing in de-escalating treatment of bloodstream infections 
and that communication between clinicians, epidemiologists and microbiologists had greatly 
improved. The efforts also laid the foundation for a laboratory-based surveillance system for 
antimicrobial resistance which enabled Georgia to provide data for the CAESAR annual report 
(35) for the first time in 2017. Currently, Armenia is performing a PoP study and more studies 
are being prepared in Uzbekistan and Tajikistan.
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The regional average of the 
total expenditure on health as 
a percentage of GDP remained 
almost unchanged between 2010 
and 2014
Total health expenditure is measured as the sum 
of general government and private expenditure 
on health (1). Estimates for this indicator are pro-
duced by WHO jointly with the Organisation for 
Economic Co-operation and Development and the 
World Bank (1).
The WHO European regional average of total health 
expenditure as a percentage of GDP has steadily 
increased from 6.8% in 2000 to 8.5% in 2009 but 
then fell slightly and remained almost unchanged 
at 8.3% in 2010 and 8.2% in 2014 (Fig. 2.34).
However, there were large differences in levels of 
total health expenditure as a percentage of GDP 
between the countries in the Region. Expenditure 
ranged from 2.1% to a maximum value of 11.9% 
in 2014 (see Fig. 2.34). The difference between 
the countries with the highest and lowest rates of 
expenditure in the Region has widened since 2005 
but has remained at around 10 percentage points 
since 2010 (see Fig. 2.34). There were large intra-
regional differences as expenditure ranged from 
6.6% in CIS countries to 10.8% in Nordic countries.
Figure 2.34. Total health expenditure as a proportion of GDP (WHO estimates) (%)
Source: Health for All database on the WHO European Health Information Gateway (9).
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Continued increment in the regional 
average of private households’ out-
of-pocket payments on health: the 
challenge of achieving universal 
health coverage in the Region
The level of out-of-pocket payments or expenditure 
on health is expressed as a  percentage of total 
expenditure on health (1). Private households’ 
out-of-pocket payments on health are their direct 
expenses, including gratuities and payments in 
kind made to health practitioners and suppliers 
of pharmaceuticals, therapeutic appliances and 
other goods and services, whose primary purpose 
is to contribute to the restoration or enhancement 
of the health status of individuals or population 
groups (1). They also include household payments 
to public services, non-profit institutions or non-
governmental organizations, nonreimbursable 
cost sharing, deductibles, co-payments and fees 
for service (1). The evidence shows that there is 
a  strong correlation between a  country’s public 
expenditure on health and private out-of-pocket 
payments (36, 37 p. 29). Countries with low levels 
of public expenditure on health usually experience 
high levels of out-of-pocket payments, which in 
turn may lead to financial hardship for households 
and adverse effects on health outcomes.
International analysis suggests that once the 
share of out-of-pocket payments falls below 15% 
of total spending on health, very few households 
experience catastrophic or impoverishing levels 
of health expenditure (38). In 2014, 40 countries 
in the Region had proportions higher than this crit-
ical threshold, similar to the findings reported in 
the European health report for 2015.
The regional average of private household out-of-
pocket expenditure has slightly increased from 
25.5% in 2010 to 26.6% in 2014 (see Fig. 2.35). 
This indicates an increase in inequitable access 
to health care along with an elevated level of 
financial risk, impoverishment and perpetuation 
of an economically vulnerable population.
There were large differences in the proportions of 
private household out-of-pocket expenditure be-
tween the countries in the Region, which ranged 
from a low value of 5.2% to a very high maximum 
value of 72.1% in 2014 (see Fig. 2.35).
There were also considerable differences be-
tween subregions in the proportions of private 
household out-of-pocket expenditure, which 
ranged from 14.7% in Nordic countries to 46.2% in 
CIS countries in 2014.
66 European Health Report 2018
General government expenditure 
on health as a percentage of GDP 
remained static between 2010 and 2014
There is an additional indicator for this target that 
concerns general government expenditure on 
health as a percentage of GDP (1).
General government expenditure on health is the 
sum of total expenditure for health maintenance, res-
toration or enhancement paid for in cash or supplied 
in kind by government entities, such as ministries 
of health and other ministries, parastatal organiza-
tions and social security agencies (without double 
counting the government transfer for social security 
and to extra budgetary funds) (1). It includes trans-
fer payments to households to offset medical care 
costs to finance health services and goods (1).
The regional average of the general government 
expenditure on health as a percentage of GDP re-
mained steady at 5.8% in 2010 and 5.7% in 2014.
There are large differences in the levels of general 
government expenditure on health between the 
countries in the Region. In 2014, the highest 
reported value for general government expenditure 
on health was 10% and the lowest was 1%. Since 
2010 the highest level of general government 
expenditure on health in the Region has increased 
by 1 percentage point, whereas the lowest level 
has remained unchanged.
There are also considerable differences between 
subregions in the levels of general government 
expenditure on health as a  percentage of GDP, 
which ranged from 3.4% in CIS countries to 8.9% 
in the Nordic countries in 2014.
To achieve universal health coverage at the 
national level, Member States have to ensure 
that sufficient public resources are allocated 
to health and out-of-pocket payments are 
reduced to a  minimum, especially for the poor 
and other vulnerable populations. There is 
Figure 2.35. Private households’ out-of-pocket expenditure on health as a proportion of total health 
expenditure (WHO estimates) (%)
Source: Health for All database on the WHO European Health Information Gateway (9).
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an inverse relationship between a  country’s 
public expenditure on health and out-of-pocket 
payments. Countries with low levels of public 
expenditure on health usually experience high 
levels of out-of-pocket payments, which in 
turn pose a  financial risk and foster negative 
influences on health outcomes.
Slow decline in maternal deaths
An additional key indicator for this target is mater-
nal deaths per 100 000 live births (1).
It is also an SDG indicator for monitoring Goal 3.1 
which aims to “reduce the global maternal mor-
tality ratio to less than 70 per 100 000 live births” 
by 2030 (24). The maternal mortality ratio is the 
annual number of female deaths from any cause 
related to, or aggravated by, pregnancy or its 
management (excluding accidental or incidental 
causes), during pregnancy and childbirth or with-
in 42 days of the end of the pregnancy, irrespec-
tive of the duration and site of the pregnancy, per 
100 000 live births, for a specified year (1).
The WHO European Region has made considerable 
progress in closing the maternal mortality gap 
between countries; the difference between the 
highest and lowest rates is decreasing. The 
lowest rate in the Region in 2015 was 0%, while 
the highest rate was 55%.
Certain indicators  – such as infant and mater-
nal mortality, as well as various communicable 
diseases – can be affected by small numbers of 
events and the small population size, and there-
fore most year-to-year variation seen at the na-
tional level is random. The maternal mortality indi-
cator is therefore presented by calculating annual 
values using an average from the last three years 
for which data are available, having been adjusted 
using the moving averages method. The regional 
three-year moving average of maternal mortality 
rates decreased from 20 deaths per 100 000 live 
births in the period 2000–2002 to 13.7 deaths 
per 100  000 live births in 2009–2011 and 
11.3 deaths per 100 000 live births in 2013–2015 
(see Fig. 2.36). Further, there were large differenc-
es between the countries in three-year averages 
for maternal mortality (see Map 2.2).
Figure 2.36. Maternal deaths per 100 000 live births, three-year moving average
Source: Health for All database on the WHO European Health Information Gateway (9).
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Map 2.2. Maternal deaths per 100 000 live births, three-year moving average, latest available data
Source: Health for All database on the WHO European Health Information Gateway (9).
Note: The map represents the average value per country based on the three most recent years for which data were available. 
See Table A2.1 in Annex 2 for information on the data underlying this map.
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Modest treatment success rates 
for new pulmonary TB cases: 
77% by 2015
A third additional indicator for this target is treat-
ment success rate (%) for new smear-positive pul-
monary TB cases (1).
The cure rate or treatment success rate (those 
cured plus those that successfully completed 
treatment without bacteriological evidence) of 
sputum smear-positive pulmonary TB cases is 
the most reliable indicator (1). The TB treatment 
success rate is the proportion of new smear-
positive TB cases registered under a  national 
TB control programme in a  given year that 
successfully completed treatment (without 
bacteriological evidence of success) (1).
The regional average treatment success rate has 
slightly increased over recent years from 74% in 
2010 to 77% in 2015 (see Fig. 2.37). There remain 
large differences between countries, with treat-
ment success rates ranging from a very low value 
of 10% to a maximum value of 100% in 2015.
Figure 2.37. Treatment success rate: new TB cases
Source: WHO Global Health Observatory (15).
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Introduction
An important element of Health 2020 is its ac-
countability mechanisms through Target 6 which 
requests Member States to set national goals and 
targets related to health.
In 2016, the majority of Member States provided 
feedback and evidence documenting their actions 
in relation to Target 6 (27). Using data obtained 
from a  survey conducted by the WHO Regional 
Office for Europe on the qualitative indicators for 
Target 6, this midpoint assessment of the Health 
2020 policy deployment in the Region showed 
that an increased number of Member States are 
effectively aligning national policies with Health 
2020 policy, adopting the required implementation 
plans, and establishing accountability mechanisms 
for monitoring and assessing their progress.
Member States have shown a high level of com-
mitment by the adoption of various approach-
es to align their national policies and strategies 
with Health 2020 policy, which has been infused 
into the national policies in many countries in 
the Region (27). The most common approaches 
addressed a whole-of-government approach, im-
proved governance for health and improved uni-
versal health coverage.
There are still, however, many opportunities to con-
tinue developing policies and strategies to adopt, 
implement and integrate the Health 2020 values 
into policies across the Region. The implementation 
of Health 2020 should be sustained to ensure that 
health and well-being continue to be systematically 
addressed at country level through the comprehen-
sive lens of the Health 2020 policy framework and its 
core values. These actions will also directly imple-
ment the strategic priority (and goal) that the World 
Health Assembly set forth in WHO’s Thirteenth gen-
eral programme of work 2019–2023: “Through an in-
tegrated and multi-sectoral approach, 1 billion more 
people enjoying better health and well-being” (33).
Target 6.  
Set national goals and targets related to health
Box 2.13. Health 2020 Target 6 and indicators
Target 6 is “national targets/goals set by Member States” and is linked to Health 2020 
area 3 “Processes, governance and health systems”. The description of this target is the 
establishment of processes for the purpose of setting national targets (if not already in 
place). The core indicators linked to this target are:
• establishment of a process for target-setting documented
• evidence documenting:
 › establishment of national policies aligned with Health 2020
 › implementation plan
 › accountability mechanism.
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Thirty-eight countries have either set 
goals and targets for health and well-
being or are planning to do so in the 
near future
Target-setting processes are established national 
procedures for setting health goals, objectives, 
targets or indicators aligned with Health 2020 (1). 
They are expected to be documented in Member 
State reports (1).
In 2014, the Regional Office conducted the first 
survey among Member States to collect informa-
tion for the qualitative indicators linked to Target 
6, for the baseline year (2010) and the first com-
parison year (2013). A follow-up survey was con-
ducted in 2017 and the report with the complete 
analysis and findings was published and made 
available online (27).
This section briefly reports on the results of the 
three surveys on Health 2020 policy indicators 
linked to Target 6 for 2010, 2013 and 2016. Thir-
ty-three countries provided responses in 2010, 40 
in 2013, and 43 in 2016 (see Fig. 2.38). Between 
2010 and 2016, Member States were actively set-
ting targets and indicators for health and well-be-
ing, with only a few countries left in the initial plan-
ning stages by 2016.
The percentage of responding countries that re-
ported that they had set either targets or indica-
tors for health and well-being, or were planning 
to do so in the near future increased from 73% in 
2010, to 80% in 2013, and 88.4% (38 countries of 
the 43 that responded to the survey) in 2016 (see 
Fig. 2.38). Meanwhile, the percentage of coun-
tries that reported that they did not yet have a pro-
cess or did not plan at all to define the process of 
setting targets and indicators dropped from 27% 
in 2010, to 20% in 2013 and 12% in 2016. By 2016, 
less than 7% of the countries in the Region report-
ed that they had no plans to set up such process-
es in the future.
Figure 2.38. Number of countries with a process for target-setting for health and well-being, in 
2010, 2013, and 2016 (2010: n = 33; 2013: n = 40; 2016: n = 43)
Source: WHO Regional Office for Europe (27).
Note: A different number of countries responded in each year (2010: n = 33; 2013: n = 40; 2016: n = 43). Twenty-eight countries 
responded in all three years.
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Rapid implementation of health 
policies aligned with Health 2020
Considering data from countries that responded to 
the surveys (in 2010, 2013, and 2016), the propor-
tion of countries in the Region with a  comprehen-
sive national health policy aligned with Health 2020 
has increased from 36.4% in 2010 to 62.5% in 2013 
and 62.7% in 2016 (see Fig. 2.39). Furthermore, the 
proportion of countries in the Region who reported 
that they had another similar strategy has increased 
from 21% in 2010 to 30% in 2016. Overall, by 2016, 
95% of the countries in the Region reported that they 
had either developed the required health policy, had 
a similar strategy or were planning to develop such 
a strategy in the near future. Meanwhile, the propor-
tion of countries in the Region who reported that 
they had not established such policies decreased 
from 42% in 2010 to 22.5% in 2013 and 7% in 2016.
Diverse approaches have been taken by Member 
States to align their national policies and strategies 
with Health 2020 (27), including:
• addressing improved governance for health 
and taking a whole-of-government approach;
• addressing the reduction of health inequality 
or tackling the social determinants of health;
• adopting participatory approaches for policy 
development;
• featuring investment in a life-course approach 
and improving personal health and well-being 
skills and resilience;
• addressing major national health threats and 
challenges;
• addressing universal health coverage and 
patient-centred health care and public health 
services;
• including a whole-of-society approach, increas-
ing social capital and empowerment; and
• implementing supportive environments con-
ducive to health and well-being.
In 2010, the most common approaches for 
aligning national health policies and strategies 
with Health 2020 were to address major health 
challenges and threats (67%), health inequali-
ties (61%) and foster participation among stake-
holders (64%). By 2016, use of these approaches 
continued to increase, but the ones most fre-
quently used were those improving governance 
or taking a whole-of-government approach, and 
those focused on improving universal health 
coverage and patient-centred care. The latter 
two also have the largest increase in the share of 
responses between 2010 and 2016.
The proportion of responding countries with 
an implementation plan for national policies 
and strategies aligned with Health 2020 has in-
creased from 28% in 2010 to 50% in 2013 and 
67% in 2016 (see Fig. 2.40). Overall, by 2016, 
86% of the countries in the Region reported that 
they had either adopted an implementation plan 
or were in the process of doing so. In line with 
that, the proportion of countries that reported 
that they did not have any implementation plans 
(and had no plans to introduce any in the future) 
decreased from 27% in 2010, to 10% in 2013 
and 12% in 2016.
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Figure 2.39. Proportion of countries with national policies and strategies aligned with Health 2020, 
in 2010, 2013, and 2016 (2010: n = 33; 2013: n = 40; 2016: n = 43)
Source: WHO Regional Office for Europe (27).
Note: A different number of countries responded in each year (2010: n = 33; 2013: n = 40; 2016: n = 43). Twenty-eight countries 
responded in all three years.
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Figure 2.40. Proportion of countries with an implementation plan for national policies and strategies 
aligned with Health 2020, in 2010, 2013, and 2016 (2010: n = 33, 2013: n = 40; 2016: n = 43)
Source: WHO Regional Office for Europe (27).
Note: A different number of countries responded in each year (2010: n = 33; 2013: n = 40; 2016: n = 43). Twenty-eight countries 
responded in all three years.
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The proportion of responding countries with an 
accountability mechanism for national policies 
and strategies aligned with Health 2020 has 
increased from 21% (7 countries) in 2010 to 
52.5% in 2013 (21 countries) and 70% (30 
countries) in 2016 (see Fig. 2.41). Overall, by 
2016, 88.4% of the countries (38 countries in the 
Region) reported that they had either developed 
the required accountability mechanisms or were 
in the process of doing so. The proportion of 
countries in the Region that reported that they 
did not have accountability mechanisms in place 
(and had no plans to introduce them) decreased 
from 54.5% (18 countries) in 2010, to 25% in 
2013 (10 countries) and 11.6% in 2016 (only five 
countries). This shows that the Member States 
are actively reporting and reviewing the impact of 
their national policies.
Figure 2.41. Proportion of countries with an accountability mechanism for national policies and 
strategies aligned with Health 2020, in 2010, 2013, and 2016 (2010: n = 33; 2013: n = 40; 2016: n = 43)
Source: WHO Regional Office for Europe (27).
Note: A different number of countries responded in each year (2010: n = 33; 2013: n = 40; 2016: n = 43). Twenty-eight countries 
responded in all three years.
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Looking across all Health 2020 targets and in-
dicators, the most significant changes were 
observed for Target 6. As Member States are 
effectively progressing towards the final imple-
mentation of Health 2020, the activities, policies 
and accountability mechanisms are an important 
complement to the achievement of Agenda 2030 
along with its SDGs for health.
Since the inception of the Health 2020 policy 
framework in 2012, the Member States in the Re-
gion have increasingly embraced Health 2020’s 
core concepts such as whole-of-government and 
whole-of-society approaches to policy-making, 
catalysing intersectoral action for health and 
well-being, and supporting the development of re-
silient communities and promoting healthy lives 
across all ages.
In line with these achievements, European Member 
States have adopted a number of recent European 
regional action plans and strategies such as the 
European action plan to strengthen the use of 
evidence, information and research for policy-
making (39) and its accompanying resolution. In 
action area 4 of the plan, Member States directly 
emphasized the European Region’s commitment 
to mainstreaming the use of evidence, information 
and research in the implementation of Health 
2020 and other major regional policy frameworks. 
This commitment will further strengthen national 
policy-making and strengthen the monitoring and 
accountability mechanisms measuring the impact 
of policies on population health and well-being. The 
WHO European Member States have put principles 
and systems in place that recognize health and well-
being’s cross-cutting nature in the aspirations of 
Agenda 2030 for sustainable development.
Box 2.14. Implementing the sustainable development goals in the WHO 
European Region
Background
In 2017, Ministers of Health, at the Regional Committee, reaffirmed the importance of the 
adoption of Transforming our world: the 2030 agenda for sustainable development and, 
recognizing the sustainable development goals (SDGs), adopted the European roadmap to 
implement the SDGs, building on Health 2020, the European policy framework for health 
and well-being. The nationalization and localization of Agenda 2030 has been initiated in 
almost all of the WHO European Member States. Important discussions are being held on 
the identification of the indicators, the target benchmarks, mainstreaming the SDGs into 
policies and strategies, policy coherence and the identification of means of implementation, 
including financing. A range of tools and partnerships have been developed by the Regional 
Office to support implementation in countries.
UN coordination
In May, within the Regional Coordination Mechanism of the Regional UN System for Europe and 
Central Asia, the Issue-based Coalition on Health and Well-being for All at All Ages (IBC-Health) 
was welcomed as a  useful means by which agencies could cooperate on health (40). The 
coalition of partners acts as a pan-European enabling mechanism to facilitate and to promote 
the implementation of SDG 3 and its targets as well as the health-related targets of the other 
SDGs by coordinating activities of the relevant UN funds, programmes and specialized agencies 
and other intergovernmental organizations and partners, with a focus on leaving no one behind.
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Box 2.14 contd.
In response to Members States’ call for more coordinated UN engagement, the UN Director-
General introduced Mainstreaming, Acceleration and Policy Support (MAPS) missions, the 
common approach to support implementation of the 2030 Agenda at the country level.
Generating evidence for action
WHO has created SDG health target fact sheets to synthesize the evidence base on key 
health targets in order to promote coherence and better address the burden of disease 
throughout the Region (41). These fact sheets integrate discussion on current trends, health 
benefits or influences on a variety of SDGs, with policies required, the tools available and 
indicators to measure progress.
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